227 related articles for article (PubMed ID: 34608677)
21. Serum calprotectin is not an independent predictor of severe COVID-19 in ambulatory adult patients.
Mentzer AJ; James T; Yongya M; Cox S; Paddon K; Shine B; Bowen J; Novak A; Knight JC; Fullerton JN
J Infect; 2022 Feb; 84(2):e27-e29. PubMed ID: 34843810
[No Abstract] [Full Text] [Related]
22. Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients.
Chapuis N; Ibrahimi N; Belmondo T; Goulvestre C; Berger AE; Mariaggi AA; Andrieu M; Chenevier-Gobeaux C; Bayle A; Campos L; Cheurfa C; Chocron R; Diehl JL; Doumenc B; Duchemin J; Duprat M; François F; Gendron N; Mirault T; Pène F; Philippe A; Pommeret F; Sanchez O; Smadja DM; Szwebel TA; Silvin A; Ginhoux F; Lacroix L; Jules-Clément G; Rapeteramana S; Mavier C; Steller L; Perniconi B; André F; Drubay D; Fontenay M; Hüe S; Paul S; Solary E
EBioMedicine; 2022 Jun; 80():104077. PubMed ID: 35644124
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of different immunoassays for the detection of antiphospholipid antibodies: report of a wet workshop during the 13th International Congress on Antiphospholipid Antibodies.
Forastiero R; Papalardo E; Watkins M; Nguyen H; Quirbach C; Jaskal K; Kast M; Teodorescu M; Lakos G; Binder W; Shums Z; Nelson V; Norman G; Puig J; Cox A; Vandam W; Hardy J; Pierangeli S
Clin Chim Acta; 2014 Jan; 428():99-105. PubMed ID: 24252665
[TBL] [Abstract][Full Text] [Related]
24. Antiphospholipid Antibodies Occurrence in Acute SARS-CoV-2 Infection without Overt Thrombosis.
Dima A; Popescu DN; Moroti R; Stoica E; State G; Negoi F; Berza IA; Parvu M
Biomedicines; 2023 Apr; 11(5):. PubMed ID: 37238912
[TBL] [Abstract][Full Text] [Related]
25. Serum calprotectin as a biomarker for Crohn's disease.
Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E;
J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231
[TBL] [Abstract][Full Text] [Related]
26. Calprotectin (S100A8/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis.
Turina MC; Yeremenko N; Paramarta JE; De Rycke L; Baeten D
Arthritis Res Ther; 2014 Aug; 16(4):413. PubMed ID: 25135077
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: a prospective observational study.
Najim M; Rahhal A; Khir F; Aljundi AH; Abu Yousef S; Ibrahim F; Amer A; Mohamed AS; Saleh S; Alfaridi D; Mahfouz A; Alyafei S; Howady F; Khatib M; Alemadi SA
Rheumatol Int; 2021 Jul; 41(7):1243-1252. PubMed ID: 33954813
[TBL] [Abstract][Full Text] [Related]
28. Calprotectin serum levels on admission and during follow-up predict severity and outcome of patients with COVID-19: A prospective study.
Gatselis NK; Lyberopoulou A; Lygoura V; Giannoulis G; Samakidou A; Vaiou A; Antoniou K; Triantafyllou K; Stefos A; Georgiadou S; Sagris D; Sveroni D; Gabeta S; Ntaios G; Norman GL; Dalekos GN
Eur J Intern Med; 2024 Apr; 122():78-85. PubMed ID: 37953124
[TBL] [Abstract][Full Text] [Related]
29. Calprotectin and calgranulin C serum levels in bacterial sepsis.
Bartáková E; Štefan M; Stráníková A; Pospíšilová L; Arientová S; Beran O; Blahutová M; Máca J; Holub M
Diagn Microbiol Infect Dis; 2019 Mar; 93(3):219-226. PubMed ID: 30420210
[TBL] [Abstract][Full Text] [Related]
30. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis.
Zhao Y; Yin L; Patel J; Tang L; Huang Y
J Med Virol; 2021 Jul; 93(7):4358-4369. PubMed ID: 33739452
[TBL] [Abstract][Full Text] [Related]
31. Serum Calprotectin Versus Acute-Phase Reactants in the Discrimination of Inflammatory Disease Activity in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors.
Inciarte-Mundo J; Victoria Hernández M; Ruiz-Esquide V; Raquel Cabrera-Villalba S; Ramirez J; Cuervo A; Pascal M; Yagüe J; Cañete JD; Sanmarti R
Arthritis Care Res (Hoboken); 2016 Jul; 68(7):899-906. PubMed ID: 26841119
[TBL] [Abstract][Full Text] [Related]
32. Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization.
Fukunaga S; Kuwaki K; Mitsuyama K; Takedatsu H; Yoshioka S; Yamasaki H; Yamauchi R; Mori A; Kakuma T; Tsuruta O; Torimura T
Int J Mol Med; 2018 Jan; 41(1):107-118. PubMed ID: 29115397
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory markers in gynecologic oncology patients hospitalized with COVID-19 infection.
Smith M; Lara OD; O'Cearbhaill R; Knisely A; McEachron J; Gabor L; Carr C; Blank S; Prasad-Hayes M; Frey M; Jee J; Fehniger J; Wang Y; Lee YC; Isani S; Wright JD; Pothuri B
Gynecol Oncol; 2020 Dec; 159(3):618-622. PubMed ID: 33019984
[TBL] [Abstract][Full Text] [Related]
34. Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
Hasan Ali O; Bomze D; Risch L; Brugger SD; Paprotny M; Weber M; Thiel S; Kern L; Albrich WC; Kohler P; Kahlert CR; Vernazza P; Bühler PK; Schüpbach RA; Gómez-Mejia A; Popa AM; Bergthaler A; Penninger JM; Flatz L
Clin Infect Dis; 2021 Nov; 73(9):e2869-e2874. PubMed ID: 32997739
[TBL] [Abstract][Full Text] [Related]
35. Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis.
Tepasse PR; Vollenberg R; Fobker M; Kabar I; Schmidt H; Meier JA; Nowacki T; Hüsing-Kabar A
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34202697
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic yield of bacteriological tests and predictors of severe outcome in adult patients with COVID-19 presenting to the emergency department.
Kaal A; Snel L; Dane M; van Burgel N; Ottens T; Broekman W; El Bouazzaoui L; Kolfschoten N; Schippers E; Steyerberg E; Meziyerh S; van Nieuwkoop C
Emerg Med J; 2021 Sep; 38(9):685-691. PubMed ID: 34289966
[TBL] [Abstract][Full Text] [Related]
37. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
[TBL] [Abstract][Full Text] [Related]
38. Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis.
Jarlborg M; Courvoisier DS; Lamacchia C; Martinez Prat L; Mahler M; Bentow C; Finckh A; Gabay C; Nissen MJ;
Arthritis Res Ther; 2020 May; 22(1):105. PubMed ID: 32375861
[TBL] [Abstract][Full Text] [Related]
39. The Diagnostic Value of New Additional Antiphospholipid Antibodies in Antiphospholipid Syndrome.
Khogeer H; Altahan S; Alrehaily A; Sheikh A; Awartani K; Al-Kaff M; Saleh S; Alzahrani H; Alfattani A; Owaidah T
Ann Clin Lab Sci; 2021 Jul; 51(4):552-556. PubMed ID: 34452895
[TBL] [Abstract][Full Text] [Related]
40. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.
Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M
Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
